This is a preview of subscription content, log in via an institution to check access.
References
Bonneville R, Krook MA, Chen HZ et al (2020) Detection of microsatellite instability biomarkers via next-generation sequencing. Methods Mol Biol 2055:119–132. https://doi.org/10.1007/978-1-4939-9773-2_5
Cocco E, Scaltriti M, Drilon A (2018) NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol 15(12):731–747. https://doi.org/10.1038/s41571-018-0113-0
Li K, Luo H, Huang L, Luo H, Zhu X (2020) Microsatellite instability: a review of what the oncologist should know. Cancer Cell Int 20:16. https://doi.org/10.1186/s12935-019-1091-8 (Published 2020 Jan 13)
Reches A, Ophir Y, Stein N et al (2020) Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity. J Immunother Cancer 8(1):e000266. https://doi.org/10.1136/jitc-2019-000266
Roskoski R Jr (2020) Properties of FDA-approved small molecule protein kinase inhibitors: a 2020 update. Pharmacol Res 152:104609. https://doi.org/10.1016/j.phrs.2019.104609
Sato K, Kawazu M, Yamamoto Y et al (2019) Fusion kinases identified by genomic analyses of sporadic microsatellite instability-high colorectal cancers. Clin Cancer Res 25(1):378–389. https://doi.org/10.1158/1078-0432.CCR-18-1574
Solomon JP, Benayed R, Hechtman JF, Ladanyi M (2019) Identifying patients with NTRK fusion cancer. Ann Oncol 30(Suppl_8):viii16–viii22. https://doi.org/10.1093/annonc/mdz384
Solomon JP, Linkov I, Rosado A et al (2020) NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. Mod Pathol 33(1):38–46. https://doi.org/10.1038/s41379-019-0324-7
Vanderwalde A, Spetzler D, Xiao N, Gatalica Z, Marshall J (2018) Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients. Cancer Med 7(3):746–756. https://doi.org/10.1002/cam4.1372
Zang YS, Dai C, Xu X et al (2019) Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer. Cancer Med 8(10):4699–4708. https://doi.org/10.1002/cam4.2381
Acknowledgements
The authors thank Mr. Chuang Qi, Mr. Guanghua Lu, Ms. Xueyu Yang, Mr. Wanglong Deng, Mr. Ran Ding and Mr. Qin Zhang from Simceredx for the kindly assistance.
Funding
None declared.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared no conflicts of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Informed consent was obtained from the patient.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, P., Hou, F., Wang, S. et al. A novel NECTIN4-NTRK1 fusion identified in a lung squamous cell carcinoma patient with MSI-H. J Cancer Res Clin Oncol 147, 2483–2486 (2021). https://doi.org/10.1007/s00432-021-03622-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-021-03622-6